CEACAM5 and leukemia: CSPG4-CAR T cells evinced a significantly higher CD69 and CD25 upregulation compared to control CEA-CAR T cells following co-culture with KOPN8 leukemia cells, confirming antigen-specific activation mediated via CSPG4 CAR.